In membranes purified from human blood platelets, basal guanosine triphosphate (GTP) hydrolysis is reduced by a factor of -6 by exposure to N-ethylmaleimide (10 mM 
Guanyl nucleotides play a central role in the hormonal stimulation of adenylate cyclase in various tissues. For cases where the point has been carefully studied, such stimulation is absolutely dependent on the presence ofGTP or certain ofits analogs (1) . The hypothesis has arisen that a regulatory subunit of the cyclase (i) binds GTP as the cyclase is activated and (ii) hydrolyzes the GTP as the cyclase is again deactivated. This concept has received strongest support for the turkey erythrocyte membrane. Because this preparation has a low basal level of GTP hydrolysis, it was possible to observe an increment of GTPase activity produced by adrenergic hormones (2, 3) . This hormonestimulated GTPase has several properties expected of a system that regulates the adenylate cyclase activity of these membranes.
For other membrane preparations, there is less direct evidence that GTP is hydrolyzed by a component of adenylate cyclase. A persistent activation is produced by GTP analogs whose f3,y-phosphate bond cannot be hydrolyzed enzymatically and by cholera toxin, which blocks the GTPase in turkey erythrocytes (4) . More direct proof would involve a demonstration of GTP hydrolysis that shares the properties of hormone-stimulated adenylate cyclase: (i) the dose-response relationship should resemble that for cyclase stimulation; (ii) the GTPase should be active at low GTP concentration, with a Km of <1 X 10-6 M; and (iii) the GTPase should be blocked by cholera toxin. We have verified these concepts for the prostaglandinstimulated adenylate cyclase of membranes purified from human platelets. The measurements are made possible by the fact that exposure to N-ethylmaleimide (MalNEt) markedly decreases basal GTP hydrolysis but apparently not hormone-stimulated GTPase associated with cyclase (2).
Adenylate cyclase in human platelet membranes displays the additional property of inhibition by a2-adrenergic agonists (5) . This inhibition requires guanyl nucleotides, albeit at a higher concentration than required for adenylate cyclase activation (6, 7) . The experiments thus afforded the opportunity to test whether this inhibition is accompanied by a change in GTPase activity.
MATERIALS AND METHODS ATP (GTP-free) and guanyl-5'-yl imidodiphosphate (p[NH]ppG) were from Boehringer Mannheim; prostaglandin E1 (PGE1) was a gift from Upjohn; adenyl-5'-yl imidodiphosphate (p[NH]ppA) was from ICN or Sigma; 2-mercaptoethanol was from Eastman; radiochemicals were from The Radiochemical Centre, Amersham. Cholera toxin was obtained directly from Makor Chemicals, Jerusalem, or through its distributor, Sigma. Other chemicals were from Sigma.
Platelet Membrane Preparation. Whole blood was obtained from donors who had taken no aspirin-containing drugs for 2 wk prior to blood donation, and platelet membranes were prepared by the glycerol-lysis technique (8) as described by Steer and Wood (7) . At all stages ofthe experiments, pelleted membranes were resuspended gradually by using a Teflon rod (7) . Adenylate cyclase and GTPase assays were performed within 6 hr of blood donation. Protein was determined by the method of Lowry et al (9) with bovine serum albumin as a standard.
Turkey Erythrocyte Membranes. These were prepared as described by Steer and Levitzki (10) .
Cholera Toxin Treatment. This was performed essentially as described by Kaslow et aL (11) . Cholera toxin (200 ,ug/ml) was activated by incubation for 10 min at 30°C in 2 mM dithiothreitol/50 mM sodium phosphate buffer, pH 7.1/100 mM NaCV5 mM MgCl2, with 0.2 mg of ovalbumin per ml. This solution was added in equal volume to membranes suspended (1.5 mg/ml) in 1 mM ATP/1 mM nicotinamide adenine dinucleotide/200 ,uM GTP/50 mM sodium phosphate buffer, pH 7.1, with 100 units of creatine kinase per ml. The toxin and membranes were incubated for 10 min at 30°C, and the reaction was stopped by spinning at 20,000 x g for 10 min. Membranes were then washed twice in 10 mM Tris-HCl, pH 8 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
cyclase assay (see below) or for MalNEt treatment followed by the GTPase assay.
Adenylate Cyclase Assay. The reaction mixture had a final volume of 0.2 ml containing 0.1-0.3 mg of platelet membrane protein per ml. The enzyme was assayed under "standard" and "GTPase" conditions. In the former case, the concentrations of agents in the assay were: Tris HCl (pH 8.0), 30 mM; MgCl2, 10 mM; caffeine, 33 mM; creatine phosphate, 5 mM; creatine kinase, 50 units/ml; and [a-32P]ATP (50-100 cpm/pmol), 0.2 mM. Incubations were for 10 min at 30TC. Under "GTPase" assay conditions, the incubation was for 5 min at 370C, and final concentrations of reagents in the assay mixture were exactly as described for the GTPase assay (see below), except that the radiochemical was [a-32P]ATP.
In either case, the reaction was terminated by addition of a solution containing 4 mM ATP, 1.4 mM cAMP, and 2% sodium dodecyl sulfate.
[3H]cAMP (5-10,000 cpm per assay tube) was added, and [32P]cAMP was collected by the method of Salomon et aL (12) . Recovery of [32P]cAMP was corrected by using the value obtained for [3H]cAMP recovery (50-80%).
MalNEt Treatment. This was performed essentially as described by Cassel and Selinger (2) . Membranes (0.5-1 mg of protein per ml) were incubated in 10 mM MalNEt for 30 min at 0°C. The incubation was terminated by addition of 15 mM 2-mercaptoethanol. After an additional 5 min at 0°C, the reaction was diluted 1:10 (vol/vol) with 50 mM imidazole HCl, and membranes were pelleted at 20,000 X g for 10 min. Membranes were resuspended in imidazole buffer and used for the GTPase assay.
GTPase Assay. This was performed by liberation of32Pi from [y-32P]GTP as described by Cassel and Selinger (13 ploited the turkey erythrocyte system, whose low basal GTPase activity allows measurements of epinephrine stimulation both before and after MalNEt treatment. The data (Fig. 1) show that MalNEt treatment produced little or no change in the Km for GTP and a small (44%) decrement in the maximal GTPase activity. Thus, hormone-stimulated GTPase is not greatly affected by the MalNEt treatment.
Dose-Response Characteristics for the GTPase and Cyclase. Earlier studies have shown that prostaglandin-stimulated adenylate cyclase is stimulated to half-maximal activity at PGE, concentrations on the order of 0.1 ,uM (7). The present experiments confirmed these data and showed that the PGE,-stimulated GTPase displays strikingly similar dose-response characteristics (Fig. 2) .
.Effects of Cholera Toxin. Cholera toxin affects human platelet membranes analogously to its action on turkey erythrocytes: it activates adenylate cyclase (14) , presumably by blocking hormone-stimulated GTPase (Table 2) . Because human platelet membranes have significant basal adenylate cyclase, it was of interest to determine whether basal GTPase activity was also affected by exposure to cholera toxin. There was a small decrease in the experiment of Table 2 in a second experiment under similar conditions. In both experiments, hormone-induced GTPase was reduced by a factor of =3 after exposure to cholera toxin. Therefore, the cholera toxin specifically decreases hormone-stimulated GTPase, as observed for turkey erythrocytes (4) . GTP Concentration Dependence. Human platelet membranes showed both basal and PGE1-stimulated GTPase for GTP concentrations in the range of 0.05-10 ILM (Fig. 2) . In an experiment to explore the range between zero and 2 JIM, we found that the basal GTPase was characterized by a component with a Km of 1 x 10-7 M and a second component, presumably with a much higher Km, whose rate increased linearly with GTP concentration (data not shown).
However, the prostaglandin-stimulated GTPase was characterized by a Km several times larger than 1 x 10-7 M. In the experiments of Fig. 3 and Fig. 4b , the Km was 6 X 10-7 M; and two similar experiments gave values of 4 and 6 x 10-7 M. By contrast, the prostaglandin-stimulated adenylate cyclase is activated by much lower GTP concentrations (6, 7). To provide an accurate comparison between the two enzymes, we assayed adenylate cyclase under the same conditions used in the GTPase assay, although the MalNEt treatment was omitted. (The adenylate cyclase activity was only about 1/6th of the normal value under these suboptimal conditions.) Halfmaximal stimulation was observed at 0.04 AM GTP. There was some activity even with no added GTP, perhaps because the membrane preparation itself contributed guanyl nucleotides. If so, the Km for adenylate cyclase was about 6 X 10-8 M, or about 1/10th the Km for GTP hydrolysis.
If the membrane preparation contributed GTP, this would also artifactually increase the measured Km for the GTPase by the amount contributed. Two observations render it unlikely that such a mechanism significantly distorted the GTPase results. First, a Km of 10-7 M was measured for basal GTPase . The adenylate cyclase activity was measured under the same conditions as those used in the GTPase assay. For B, a straight line was fit to the PGEI-stimulated GTPase at GTP concentrations -3 pM in the experiment of Fig. 3 . This line presumably represents a low-affinity PGE,-stimulated GTPase and was subtracted from the data. This correction is equivalent to subtracting the radioactivity released at high concentrations of unlabeled GTP in the presence of PGE1 (2) DISCUSSION GTPase and Cyclase. The data leave little doubt that the prostaglandin-stimulated GTPase activity is closely correlated with activation of adenylate cyclase. The dose-response characteristics match for the two enzymes, they are affected as expected by cholera toxin, and both are activated by GTP at submicromolar concentrations. This correlation seems more direct than for the prostaglandin-stimulated GTP hydrolysis recently reported for human mononuclear cells (15) . Good correlations between GTPase and adenylate cyclase also have been reported for activation by pancreozymin (16) and glucagon (17) in addition to the original observations with ,(3adrenergic agonists in erythrocytes (2, 18) .
There is, however, an interesting discrepancy between the detailed GTP concentration dependence of the two enzymes. Adenylate cyclase activity is half-maximal at about 4 X 10-8 M GTP; the Km for the GTPase is 10-fold higher. The Km values for the two enzymes would be equal in the simple scheme where (i) a molecule of cyclase is activated as a molecule of GTP binds to a regulatory component and (ii) cyclase is deactivated as GDP and Pi are released. Evidently events at the GTP binding site are coupled in a less direct fashion to the cyclase. 
